Corporate News     09-Feb-24 Biocon receives Complete Response Letter for Biologics License Application From USFDA Biocon announced that the U.S. Food and Drug Administration (US FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for bBevacizumab. The CRL did not identify any outstanding scientific issues on the dossier and informs the need for the completion of a pre-approval inspection of the bBevacizumab manufacturing facility. Previous News   Biocon Ltd up for five straight sessions  ( Hot Pursuit - 04-Feb-26   13:00 )   Biocon Ltd rises for third straight session  ( Hot Pursuit - 16-Jan-26   13:05 )   Biocon concludes QIP issue of Rs 4,150 cr  ( Corporate News - 15-Jan-26   12:10 )   Biocon to hold board meeting  ( Corporate News - 14-Jan-26   10:04 )   Stock Alert: Biocon, Senco Gold, Jubilant Foodworks, Titan Company  ( Market Commentary - Stock Alert 07-Jan-26   07:58 )   Biocon Biologics to introduce three new biosimilar oncology assets  ( Corporate News - 06-Jan-26   19:59 )   Biocon Ltd soars 0.1%, rises for fifth straight session  ( Hot Pursuit - 23-Dec-25   13:00 )   Biocon arm secures global rights for Hulio from Fujifilm Kyowa Kirin Biologics Co  ( Hot Pursuit - 23-Dec-25   11:23 )   Biocon launches its diabetes & obesity treatment drugs in Netherlands  ( Hot Pursuit - 15-Dec-25   09:45 )   Biocon launches GLP-1 peptide, Liraglutide in the Netherlands  ( Corporate News - 15-Dec-25   09:09 )   Biocon’s arm inks pact to commercialize biosimilar Aflibercept Worldwide  ( Hot Pursuit - 13-Dec-25   15:17 )	Other Stories   Board of Privi Speciality Chemicals approves additional investment in Prigiv Specialties   09-Feb-26   19:38   HMT announces appointment of Government Nominee Director   09-Feb-26   19:35   Aurobindo Pharma board considers merger of subsidiaries   09-Feb-26   19:31   Board of Aurobindo Pharma approves PPA with Garuda Renewables   09-Feb-26   19:27   Aurobindo Pharma board appoints directors   09-Feb-26   19:25   City Union Bank appoints R. Vijay Anandh as MD and CEO   09-Feb-26   19:22   Gujarat Natural Resources cancels board meeting   09-Feb-26   18:16   Brady & Morris Engineering Company revises board meeting date   09-Feb-26   18:15   W H Brady & Company revises board meeting date   09-Feb-26   18:15   Helpage Finlease postpones board meeting   09-Feb-26   18:15
Back Top